WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 2 fonti

At BIO 2026, industry wrestled with Washington politics, and making AI work better

At BIO 2026, executives reveal concerns over Chinese biotech, the profitability of AI, and the durability of Trump's drug price moves.

Raccontata da

cryptobriefing.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

statnews.comStai leggendo4 g fa

At BIO 2026, industry wrestled with Washington politics, and making AI work better

At BIO 2026, executives reveal concerns over Chinese biotech, the profitability of AI, and the durability of Trump's drug price moves.

cryptobriefing.com4 g fa

Nvidia and Genentech make the case for AI-driven drug discovery at BIO2026

Nvidia and Genentech made the case for AI-driven drug discovery at BIO2026, showcasing the BioNeMo toolkit and their multi-year partnership in life

Leggi questa versione → originale

Timeline cronologica

mercoledì 24 giugno 2026·statnews.com
A dispatch on AI from BIOtech’s big summer bash
In this edition of STAT's AI Prognosis: Brittany Trang brings the latest from BIO on how biotech companies are approaching artificial intelligence.
giovedì 25 giugno 2026·cryptobriefing.com
Nvidia and Genentech make the case for AI-driven drug discovery at BIO2026
Nvidia and Genentech made the case for AI-driven drug discovery at BIO2026, showcasing the BioNeMo toolkit and their multi-year partnership in life

giovedì 25 giugno 2026·

statnews.com

The China debate gets louder in Washington

A boom in GLP-1s and health care costs, AI-designed hair growth drugs, and more biotech news from The Readout

giovedì 25 giugno 2026·

statnews.com

At BIO 2026, industry wrestled with Washington politics, and making AI work better

At BIO 2026, executives reveal concerns over Chinese biotech, the profitability of AI, and the durability of Trump's drug price moves.

venerdì 26 giugno 2026·

statnews.com

BIO 2026: AI, federal policy impacts, and general vibes

What were the vibes like at BIO 2026? STAT reporters take you inside the annual industry conference on the latest episode of STATus Report.